Ameriprise’s MINDBODY, Inc. Class A Common Stock MB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-926,172
Closed -$33.7M 3844
2018
Q4
$33.7M Sell
926,172
-588,460
-39% -$17.9M 0.02% 780
2018
Q3
$61.6M Sell
1,514,632
-49,237
-3% -$1.92M 0.02% 646
2018
Q2
$60.4M Buy
1,563,869
+677,506
+76% +$26.7M 0.03% 587
2018
Q1
$34.5M Buy
886,363
+683,482
+337% +$24.4M 0.02% 832
2017
Q4
$6.18M Buy
202,881
+16,334
+9% +$503K ﹤0.01% 1980
2017
Q3
$4.82M Sell
186,547
-10,639
-5% -$264K ﹤0.01% 2114
2017
Q2
$5.36M Buy
197,186
+150,563
+323% +$4.14M ﹤0.01% 2014
2017
Q1
$1.28M Sell
46,623
-20,044
-30% -$516K ﹤0.01% 2783
2016
Q4
$1.42M Sell
66,667
-53,281
-44% -$1.08M ﹤0.01% 2794
2016
Q3
$2.36M Buy
+119,948
New +$2.1M ﹤0.01% 2482

Other funds holding MB

Ameriprise's MB Position: Q1 2019 in Review

Ameriprise sold out of MINDBODY, Inc. Class A Common Stock (MB) in Q1 2019, closing a stake of 926,172 shares — an estimated $33.7M sold.

Ameriprise first reported a position in MB in Q3 2016 and held it in 10 quarters. The position peaked at $61.6M in Q3 2018. 1 fund tracked by Wall St. Rank holds MB as of Q1 2019.

  • Ameriprise reported no remaining MINDBODY, Inc. Class A Common Stock position as of Q1 2019 after selling out during the quarter.
  • Ameriprise sold 926,172 MINDBODY, Inc. Class A Common Stock shares in Q1 2019, an estimated $33.7M.
  • Ameriprise first reported a position in MINDBODY, Inc. Class A Common Stock in Q3 2016 and held it in 10 quarters.
  • Ameriprise's MINDBODY, Inc. Class A Common Stock position peaked at $61.6M in Q3 2018.
  • 1 fund tracked by Wall St. Rank held MINDBODY, Inc. Class A Common Stock as of Q1 2019.

Based on Ameriprise's 13F filing for Q1 2019, filed 15 May 2019.